These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 10335856
1. Preimmunization epidemiology of hepatitis B virus infection in South African children. Vardas E, Mathai M, Blaauw D, McAnerney J, Coppin A, Sim J. J Med Virol; 1999 Jun; 58(2):111-5. PubMed ID: 10335856 [Abstract] [Full Text] [Related]
2. The decline of hepatitis B viral infection in South-Western Saudi Arabia. Ayoola AE, Tobaigy MS, Gadour MO, Ahmad BS, Hamza MK, Ageel AM. Saudi Med J; 2003 Sep; 24(9):991-5. PubMed ID: 12973485 [Abstract] [Full Text] [Related]
3. Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy). Majori S, Baldo V, Tommasi I, Malizia M, Floreani A, Monteiro G, Ferrari A, Accordini A, Guzzo P, Baldovin T. J Travel Med; 2008 Sep; 15(5):323-7. PubMed ID: 19006505 [Abstract] [Full Text] [Related]
4. Improved immunization practices reduce childhood hepatitis B infection in Tonga. Danielsson N, Fakakovikaetau T, Szegedi E. Vaccine; 2009 Jul 16; 27(33):4462-7. PubMed ID: 19508908 [Abstract] [Full Text] [Related]
5. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size. Luo Z, Xie Y, Deng M, Zhou X, Ruan B. Eur J Gastroenterol Hepatol; 2011 Aug 16; 23(8):695-700. PubMed ID: 21617533 [Abstract] [Full Text] [Related]
6. Seroepidemiology of hepatitis B infection in children in Vanuatu. Implications for vaccination strategy. Maher CP, Harris MS, Milne A, Johnston A, Stewart A, Waldon JA. Med J Aust; 1991 Feb 18; 154(4):249-53. PubMed ID: 1994198 [Abstract] [Full Text] [Related]
7. Seroprevalence of hepatitis B surface antigenaemia in children in a tertiary health institution in the Niger Delta of Nigeria. Alikor EA, Erhabor ON. Niger J Med; 2007 Feb 18; 16(3):250-1. PubMed ID: 17937164 [Abstract] [Full Text] [Related]
8. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. J Clin Virol; 2006 Jan 18; 35(1):14-20. PubMed ID: 15916918 [Abstract] [Full Text] [Related]
9. Universal immunization of infants with low doses of a low-cost, plasma-derived hepatitis B vaccine in South Africa. Schoub BD, Matai U, Singh B, Blackburn NK, Levin JB. Bull World Health Organ; 2002 Jan 18; 80(4):277-81. PubMed ID: 12075363 [Abstract] [Full Text] [Related]
10. [Long-term efficacy of infant hepatitis B immunization program]. Gong J, Li RC, Yang JY, Li YP, Chen XR, Xu ZY, Liu CB, Cao HL, Zhao K, Ni DM. Zhonghua Gan Zang Bing Za Zhi; 2003 Apr 18; 11(4):203-5. PubMed ID: 12716514 [Abstract] [Full Text] [Related]
11. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization. Hipgrave DB, Nguyen TV, Vu MH, Hoang TL, Do TD, Tran NT, Jolley D, Maynard JE, Biggs BA. Am J Trop Med Hyg; 2003 Sep 18; 69(3):288-94. PubMed ID: 14628946 [Abstract] [Full Text] [Related]
12. Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005. Cowie B, Karapanagiotidis T, Enriquez A, Kelly H. Aust N Z J Public Health; 2010 Feb 18; 34(1):72-8. PubMed ID: 20920109 [Abstract] [Full Text] [Related]
13. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ. J Med Virol; 2009 Mar 18; 81(3):406-12. PubMed ID: 19152393 [Abstract] [Full Text] [Related]
14. Prevalence of hepatitis B surface antigen among patients suspected of liver diseases in a Nigerian hospital. Baba MM, Ajayi BB, Ekanem IA. Niger Postgrad Med J; 2000 Sep 18; 7(3):91-5. PubMed ID: 11257921 [Abstract] [Full Text] [Related]
15. Trend in incidence of hepatitis B virus infection during a decade of universal childhood hepatitis B vaccination in Saudi Arabia. Madani TA. Trans R Soc Trop Med Hyg; 2007 Mar 18; 101(3):278-83. PubMed ID: 16600318 [Abstract] [Full Text] [Related]
16. Seroprevalence of hepatitis B infection in the Turkish population in Northern Cyprus. Kurugöl Z, Koturoğlu G, Akşit S, Ozacar T, Northern Cyprus Study Team, Kayimbaşoğlu S, Ozbalikçi S, Erçal G, Güllüelli E, Bakkaloğlu F, Doğan E, Garabli H, Erçal H, Mert C. Turk J Pediatr; 2009 Mar 18; 51(2):120-6. PubMed ID: 19480322 [Abstract] [Full Text] [Related]
17. Age-specific seroprevalence of hepatitis B virus infection. Kuru U, Senli S, Türel L, Kuru N, Başkent A, Ulucakli O. Turk J Pediatr; 1995 Mar 18; 37(4):331-8. PubMed ID: 8560600 [Abstract] [Full Text] [Related]
18. The impact of the hepatitis B virus vaccine on the incidence of hepatitis B virus-associated membranous nephropathy. Bhimma R, Coovadia HM, Adhikari M, Connolly CA. Arch Pediatr Adolesc Med; 2003 Oct 18; 157(10):1025-30. PubMed ID: 14557165 [Abstract] [Full Text] [Related]
19. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness. de la Hoz F, Perez L, de Neira M, Hall AJ. Int J Infect Dis; 2008 Mar 18; 12(2):183-9. PubMed ID: 17913535 [Abstract] [Full Text] [Related]
20. Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination. Papaevangelou V, Hadjichristodoulou C, Cassimos DC, Pantelaki K, Tzivaras A, Hatzimichael A, Theodoridou M. Infection; 2008 Mar 18; 36(2):135-9. PubMed ID: 18231718 [Abstract] [Full Text] [Related] Page: [Next] [New Search]